TTI-101 [Ligand Id: 12268] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL3392776 (C-188-9, Stat3 inhibitor c188-9, Stat3 inhibitor tti-101, Tti 101, Tti-101, TTI-101, TTI101)
  • signal transducer and activator of transcription 3/Signal transducer and activator of transcription 3 in Human [ChEMBL: CHEMBL4026] [GtoPdb: 2994] [UniProtKB: P40763]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
signal transducer and activator of transcription 3/Signal transducer and activator of transcription 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4026] [GtoPdb: 2994] [UniProtKB: P40763]
ChEMBL Binding affinity to full length STAT3 (unknown origin) by Surface plasmon resonance B 6.6 pKd 250 nM Kd J Med Chem (2022) 65: 6710-6728 [PMID:35476936]
ChEMBL Binding affinity to STAT3 (127 to 722 residues) (unknown origin) by microscale thermophoresis analysis B 8.33 pKd 4.7 nM Kd Eur J Med Chem (2020) 187: 111922-111922 [PMID:31810784]
ChEMBL Inhibition of STAT3 in human NB-4 cells assessed as inhibition of G-CSF induced STAT3 phosphorylation incubated for 60 mins by western blot assay B 5.08 pIC50 8300 nM IC50 Eur J Med Chem (2020) 187: 111922-111922 [PMID:31810784]
ChEMBL Inhibition of STAT3 in human KG-1 cells assessed as inhibition of G-CSF induced STAT3 phosphorylation incubated for 60 mins by western blot assay B 5.39 pIC50 4100 nM IC50 Eur J Med Chem (2020) 187: 111922-111922 [PMID:31810784]
ChEMBL Binding affinity to STAT3 (unknown origin) by SPR analysis B 5.4 pIC50 4000 nM IC50 J Med Chem (2021) 64: 8884-8915 [PMID:34170703]

ChEMBL data shown on this page come from version 34:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]